Public Health

HEDIS MY: Veradigm Changes & Omada Compliance Score

Listen to this article · 8 min listen

For health plan quality and compliance leaders, the annual HEDIS measure update is when vendor audit season unofficially kicks off. Measure churn is a hidden tax on your healthcare AI regulatory compliance calendar, one that’s easy to underestimate. The upcoming HEDIS MY 2027 cycle, which Veradigm has summarized, is bringing some huge changes that force you to re-evaluate vendor commitments right now, long before reporting season hits.

HEDIS MY: The Veradigm Summary and Its Implications

Veradigm’s recorded summary on HEDIS MY 2027 lays out some big shifts: six new measures are coming in, ten are being retired, and the push toward Electronic Clinical Data Systems (ECDS) reporting continues. These changes redefine the yardstick for your plan’s performance and, just as importantly, the performance of the tech vendors you pay for.

Adding six new measures means you’re scrambling for new data, new analytical paths, and putting new stress on your AI analytics platforms. Retiring ten measures sounds like a break, but it isn’t. You have to figure out if the expensive data and processing infrastructure you built around those retired measures can be repurposed or if it’s now just a stranded asset. What really matters is tracking which of the six new measures require automated reporting and which of the ten retired measures are still secretly feeding some internal scorecard, because that gap, that delta list, is the actual starting point for any meaningful compliance audit.

The biggest story for anyone working in AI healthcare compliance is the relentless move to ECDS reporting. This means we’re pulling data directly from EHRs and other digital sources instead of doing traditional chart abstractions. This new world obviously favors vendors who have solid, interoperable data pipelines and AI models that can actually process and standardize messy clinical data from multiple sources. It also puts a huge spotlight on data governance, lineage, and your ability to prove that automated data flows are trustworthy, especially when an AI is involved in interpreting or synthesizing that data for reporting.

Reading HEDIS MY Through the Omada Health Vendor Compliance Score

To see how this works in practice, let’s look at the HEDIS MY 2027 updates as if we were scoring a real-world vendor like Omada Health. They work in chronic care, which is always ground zero for HEDIS measures on things like disease management, preventative care, and patient engagement. While we don’t have a specific score for Omada Health under these new 2027 rules, walking through the exercise shows you exactly what you need to be digging into before the cycle begins.

A Vendor Compliance Score is basically your internal report card for a vendor. It’s the framework you use to assess if they’re meeting regulatory requirements, keeping data secure (think HIPAA, HITRUST, SOC 2), and can actually deliver the accurate data you need for HEDIS reporting. For an AI-heavy solution like Omada Health’s, this score would have to dig into their data privacy, the transparency of their algorithms (can they explain their own outputs?), and their proven ability to adapt when measure specs inevitably change.

So when Veradigm announces six new measures and ten retirements, it completely changes the test for a vendor like Omada Health. A new measure on a specific chronic care intervention that wasn’t tracked before means Omada’s platform has to prove it can now capture, process, and report that new data point. On the flip side, if a retired measure was a key part of Omada’s value proposition, you need to hear their plan for realigning their product and reporting to fit the new HEDIS reality your plan is facing.

“Measure churn changes what plans score vendors on. In AI healthcare compliance news, the recurring question is whether a vendor’s compliance story survives the next measure set, and a compliance audit starts with the delta list.”

The Delta List: Your Starting Point for Vendor Re-Scoring

For any quality and compliance leader, the first job is to build a “delta list” from Veradigm’s HEDIS MY 2027 summary. This list has to go beyond just new and retired measures. It needs to map the downstream effects on your data flows, algorithmic models, and reporting tools. A real compliance audit for the new cycle starts with this list, not with a vendor’s slick “readiness” presentation.

  • New Measures: For each of the six new measures, you have to pinpoint which of your vendors are on the hook, especially any using AI. This means getting into the weeds of their data ingestion pipelines, checking the AI model’s training data, and making sure the output formats align with the new specs. Do these new measures need data you don’t even have yet? Do they require a full retraining of existing AI models? You have to ask. Get the official details from the NCQA HEDIS Measure Specifications.
  • Retired Measures: The ten retired measures demand an equally tough review. Even though reporting stops, the systems you built around them might still be running. You need to know if some internal quality dashboard is still being fed by data from a now-defunct measure. A vendor’s inability to cleanly turn off old functions without disrupting your other analytics is a major compliance red flag.
  • ECDS Shift: The move to ECDS requires you to get technical with your vendor’s architecture. How well do they really integrate with different EHR systems? What are their data standardization processes, and what’s in place to keep data secure from source to report? This is the test for AI-native companies who claim their data pipelines are their main strength. It’s also where standards like the FDA GMLP Guiding Principles become critical for ensuring your use of AI in ECDS reporting is both effective and ethical.

Re-Scoring Vendor Commitments Before the Cycle Begins

The Veradigm summary of HEDIS MY 2027 changes is a wake-up call to re-score your vendor commitments now, not after the fact. This is a pre-emptive strike to reduce regulatory exposure and keep your quality improvement efforts on track. The Vendor Compliance Score concept, whether for Omada Health or any other vendor, gives you the template for this re-evaluation.

Health plans should be asking their vendors very specific, pointed questions:

  1. How will the platform adapt to the six new HEDIS MY 2027 measures? Show us a detailed plan for data acquisition, processing, and reporting for each relevant new measure.
  2. What’s the strategy for phasing out the ten retired measures? Prove you can do it without disrupting our existing analytics or internal quality metrics.
  3. Detail your ECDS capabilities for HEDIS MY 2027. What are the interoperability standards, data governance protocols, and how do your AI models ensure accurate, reliable automated reporting?
  4. How do your internal quality management systems (QMS), for instance something compliant with ISO 13485 Standard Overview, ensure that these required HEDIS changes are managed and validated rigorously?

The HEDIS MY 2027 shift is going to test the agility and foresight of both health plans and their vendor partners. By taking the delta list from Veradigm’s summary and applying it directly to your vendor compliance frameworks, you can make sure your AI healthcare regulatory compliance is solid and your vendor ecosystem is actually ready for what’s coming.

Frequently Asked Questions

What are the key changes in HEDIS MY 2027 that will impact our vendor commitments?

HEDIS MY 2027 introduces six new measures, retires ten existing measures, and continues to emphasize Electronic Clinical Data Systems (ECDS) reporting. These changes require a re-evaluation of vendor capabilities and data handling processes.

How should we approach re-evaluating our vendors given the HEDIS MY 2027 changes?

Health plans should generate a ‘delta list’ based on Veradigm’s summary, identifying the impact of new and retired measures on data flows, algorithmic dependencies, and reporting capabilities. This list forms the basis for a compliance audit and re-scoring vendors.

What is the significance of the continued emphasis on ECDS reporting for our AI-driven vendors?

The continued emphasis on ECDS reporting favors vendors with robust, interoperable data ingestion capabilities and AI models that can process and standardize diverse clinical data. It also elevates the importance of data governance and the trustworthiness of automated data flows, especially with AI involvement.

How do new and retired measures affect the Vendor Compliance Score for AI-driven solutions?

New measures will require AI platforms to demonstrate the ability to capture, process, and report on new data points. For retired measures, health plans need to understand how vendors will realign their offerings and reporting if those measures were key components of their reported value.

Share
Was this article helpful?

Editorial Team

The Editorial Team at Healthcare AI Compliance Watch is a group of writers and editors who cover health, workplace wellness, and everyday care. They research each story and publish under a shared desk byline — experts in their fields, working as one team.